IDEX Health & Science Technologies — Net Sales decreased by 2.3% to $398.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.7%, from $341.50M to $398.40M. Over 4 years (FY 2021 to FY 2025), Health & Science Technologies — Net Sales shows an upward trend with a 7.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing demand for the segment's specialized products, while a decrease may signal market saturation or competitive pressure.
Represents the total revenue generated from the sale of products and services within the Health and Science Technologies...
Comparable to revenue metrics for life science instrumentation or medical component divisions at diversified industrial peers.
iex_segment_health_science_technologies_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $275.00M | $302.30M | $294.10M | $315.20M | $326.00M | $345.00M | $353.00M | $351.00M | $339.50M | $313.20M | $312.70M | $310.10M | $303.80M | $311.00M | $373.20M | $341.50M | $365.30M | $381.00M | $407.70M | $398.40M |
| QoQ Change | — | +9.9% | -2.7% | +7.2% | +3.4% | +5.8% | +2.3% | -0.6% | -3.3% | -7.7% | -0.2% | -0.8% | -2.0% | +2.4% | +20.0% | -8.5% | +7.0% | +4.3% | +7.0% | -2.3% |
| YoY Change | — | — | — | — | +18.5% | +14.1% | +20.0% | +11.4% | +4.1% | -9.2% | -11.4% | -11.7% | -10.5% | -0.7% | +19.3% | +10.1% | +20.2% | +22.5% | +9.2% | +16.7% |